Clinical Trials Directory

Trials / Completed

CompletedNCT02445313

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Doheny Image Reading Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Detailed description

To test the quality of images from the Nidek MP-3 device and to measure Geographic Atrophy (GA) in patients with Age-related Macular Degeneration (AMD).

Conditions

Interventions

TypeNameDescription
DEVICENidek MP-3Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD

Timeline

Start date
2015-06-01
Primary completion
2019-02-12
Completion
2019-02-12
First posted
2015-05-15
Last updated
2019-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02445313. Inclusion in this directory is not an endorsement.

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device (NCT02445313) · Clinical Trials Directory